Merz Pharma Canada Ltd. Announces Exclusive Distribution Arrangement For Anteis Dermal Fillers

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TORONTO--(BUSINESS WIRE)--Merz Pharma Canada, Ltd., affiliate of the global Merz Pharma Group, today announced that it has an exclusive arrangement with Anteis S.A. (Switzerland) which grants Merz sole rights for the marketing and distribution of the full line of Anteis products in Canada, including the Esthélis™, Fortélis™, Modélis™ and Mesolis™ brands and the Anteis Injection System.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC